LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM MACROGLOBULINEMIA

Clinical trials for LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM MACROGLOBULINEMIA explained in plain language.

Never miss a new study

Get alerted when new LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM MACROGLOBULINEMIA trials appear

Sign up with your email to follow new studies for LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo aims to control Slow-Growing blood cancer without chemo

Disease control Not yet recruiting

This study tests a three-drug combination (pomalidomide, an anti-CD20 antibody, and prednisone) as a first treatment for people with slow-growing B-cell lymphomas. About 30 adults who have not had prior treatment will receive six cycles of the drugs, followed by two years of main…

Matched conditions: LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM MACROGLOBULINEMIA

Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Jun 16, 2026 12:49 UTC

LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM MACROGLOBULINEMIA

Get alerted when new LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM MACROGLOBULINEMIA trials appear

New combo aims to control Slow-Growing blood cancer without chemo